SCHEMBL29920568

SCHEMBL29920568

NS(=O)(=O)C[C@H]1CC2(CC2)Oc2cc(F)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
CA2 P00918 1/20 0.35
SCD O00767 1/20 0.35
TRPV1 Q8NER1 3/20 0.34
KCNE1 P15382 3/20 0.33
KCNQ1 P51787 3/20 0.33
NR3C1 P04150 3/20 0.33
NR3C2 P08235 3/20 0.33
CFTR P13569 2/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
DRD2 P14416 1/20 0.33
SSTR5 P35346 1/20 0.32
KCNH2 Q12809 1/20 0.32
LTB4R Q15722 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29920313 1.00 PSEN1 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29920475 1.00 PSEN1 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29920748 0.95 TRPV1 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29920373 0.95 TRPV1 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29920312 0.85 TRPV1 (0.43) TRPV1KCNE1KCNQ1CFTR
SCHEMBL29920334 0.85 TRPV1 (0.43) TRPV1KCNE1KCNQ1CFTR
SCHEMBL29920502 0.72 CA2 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29920566 0.72 CA2 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL619207 0.70 TRPV1 (0.37) TRPV1HTR2AHTR2CDRD2HTR2B
SCHEMBL4355338 0.69 KDM1A (0.36) TRPV1HTR2AHTR2CDRD2HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022217248-A1 SUBSTITUTED SULFONAMIDE-CHROMAN COMPOUNDS, AND PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2022-10-13 WO disclosed